New drug reimbursement list comes into force
…– the active substances risperidone, sulpiride, aripiprazole, ziprasidone and topiramate were granted reimbursement status for off-label use in Tourette’s syndrome. Furthermore, amantadine was granted off-label reimbursement status – for the treatment of dyskinesia in adults.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)